Treatment of metastatic renal cancer with high-dose interleukin-2 after targeted therapy.

被引：0
|
作者：
Hawkins, Robert E.
Galvis, Victoria
Shanks, Jonathan
Dalal, Neha
Thistlethwaite, Fiona
Spencer-Shaw, Andrea
机构：
[1] Christie Canc Res UK, Manchester, Lancs, England
[2] Christie, Manchester, Lancs, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页数：1
相关论文
共 50 条
  • [1] REDUCTION OF TESTOSTERONE SYNTHESIS AFTER HIGH-DOSE INTERLEUKIN-2 THERAPY OF METASTATIC CANCER
    MEIKLE, AW
    DESOUSA, JCC
    WARD, JH
    WOODWARD, M
    SAMLOWSKI, WE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (05): : 931 - 935
  • [2] HIGH-DOSE INTERLEUKIN-2 IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
    PARKINSON, DR
    SZNOL, M
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 61 - 66
  • [3] High-dose interleukin-2 in metastatic renal cell carcinoma
    Fernández-Rodríguez, R
    de Argumedo, GL
    Mañé, JM
    Muñoz, A
    Ferreiro, J
    Fuente, N
    López-Vivanco, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6797 - 6798
  • [4] Treatment of Metastatic Renal Cancer With High-dose Interleukin-2 After Targeted Therapy Can Be Given Safely and Can Produce High Rates of Response Including Complete Remissions
    Hawkins, R.
    Sikand, K.
    Shanks, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S515 - S515
  • [5] High-dose interleukin-2 therapy for metastatic renal cell carcinoma: A contemporary experience
    Aboumohamed, Ahmed A.
    Yarlagadda, Naveen
    Creighton, Terrance
    Mehedint, Diana
    Attwood, Kristopher
    Kauffman, Eric
    George, Saby
    Khushalani, Nikhil I.
    Pili, Roberto
    Schwaab, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma: A Contemporary Experience
    Hanzly, Michael
    Aboumohamed, Ahmed
    Yarlagadda, Naveen
    Creighton, Terrance
    Digiorgio, Lorenzo
    Fredrick, Ariel
    Rao, Gaurav
    Mehedint, Diana
    George, Saby
    Attwood, Kristopher
    Kauffman, Eric
    Narashima, Deepika
    Khushalani, Nikhil I.
    Pili, Roberto
    Schwaab, Thomas
    UROLOGY, 2014, 83 (05) : 1129 - 1134
  • [7] Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer?
    Dillman, Robert O.
    Barth, Neil M.
    VanderMolen, Louis A.
    Fong, Warren H.
    Mahdavi, Khosrow K.
    McClure, Stephanie E.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2011, 26 (03) : 273 - 277
  • [8] High-Dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma and Metastatic Melanoma: Still the Standard
    Dutcher, Janice P.
    ONCOLOGY-NEW YORK, 2011, 25 (05): : 427 - 428
  • [9] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    McDermott, David F.
    MEDICAL ONCOLOGY, 2009, 26 : 13 - 17
  • [10] High-dose interleukin-2 in metastatic renal cell carcinoma - Reply
    McDermott, DF
    Atkins, MB
    Regan, MM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6798 - 6799
12345